Literature DB >> 20803149

Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.

Anita Chopra1, Venkateswaran K Iyer, Sandeep Agarwala, Sandeep R Mathur, Manju Aron, Siddharth Datta Gupta, Kusum Verma.   

Abstract

PURPOSE: To evaluate Bcl-xL, Bax, PCNA, cytokeratin 19 (CK-19), glycogen content and DNA ploidy expression in hepatoblastoma (HB) and their prognostic value.
METHODS: This retrospective study on 26 cases of HB involved DNA ploidy estimations separately for various subtypes on histological sections using image cytometry of Feulgen-stained smears. Glycogen content, PCNA, CK-19, Bax and Bcl-xL expression on tissue sections were evaluated. THE outcome on follow-up (mean 86 months) and Kaplan-Meier survival analysis were performed.
RESULTS: Fetal areas were diploid (84%); embryonal areas were aneuploid (89.47%) (p < 0.001). PCNA labeling index was low in fetal (10.82%) and high in embryonal areas (59.85%) (p = 0.03). CK-19 was negative in fetal, but focally positive in embryonal areas. Bax was negative in fetal (80%) and positive in embryonal areas (88.23%) (p < 0.001); Bcl-xL was more frequently positive in fetal (90%) than embryonal areas (52.94%) (p = 0.02). Fetal cells were rich in glycogen. Kaplan-Meier survival analysis showed good initial radiological response to chemotherapy (p = 0.009), glycogen content (p = 0.0137) and DNA diploid cases (p = 0.0429) were associated with good outcome on univariate analysis. Histology typing (p = 0.085), Bcl-xL (p = 0.689), Bax (p = 0.27), CK-19 (p = 0.281), PCNA (p = 0.689), age (p = 0.24), sex (p = 0.5661), stage (p = 0.24) and α-fetoprotein levels (p = 0.49) were unrelated to outcome. Multivariate analysis showed glycogen content to be the most statistically significant variable (0.024).
CONCLUSION: Fetal and embryonal areas show different staining patterns for PCNA, Bax and Bcl-xL. DNA ploidy and glycogen content are significant prognostic variables.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803149     DOI: 10.1007/s00383-010-2699-x

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  12 in total

1.  Wilms' tumor. Role of fine needle aspiration and DNA ploidy by image analysis in prognostication.

Authors:  V K Iyer; K Kapila; S Agarwala; A K Dinda; K Verma
Journal:  Anal Quant Cytol Histol       Date:  1999-12       Impact factor: 0.302

2.  Prognostic factors and staging systems in childhood hepatoblastoma.

Authors:  D von Schweinitz; H Hecker; G Schmidt-von-Arndt; D Harms
Journal:  Int J Cancer       Date:  1997-12-19       Impact factor: 7.396

3.  Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.

Authors:  M Rugge; F Sonego; L Pollice; G Perilongo; M Guido; G Basso; V Ninfo; N Pennelli; C Gambini; M Guglielmi; A Fabiano; G Leandro; J W Keeling
Journal:  Liver       Date:  1998-04

4.  Midterm results with hepatectomy after preoperative chemotherapy in hepatoblastoma.

Authors:  Minu Bajpai; K Pal; S Agarwala; Tulika Seth; Arun K Gupta
Journal:  Pediatr Surg Int       Date:  2005-04-19       Impact factor: 1.827

5.  The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation.

Authors:  Gregory M Tiao; Nicola Bobey; Steven Allen; Neris Nieves; Maria Alonso; John Bucuvalas; Robert Wells; Frederick Ryckman
Journal:  J Pediatr       Date:  2005-02       Impact factor: 4.406

Review 6.  Management of liver tumors in childhood.

Authors:  Dietrich von Schweinitz
Journal:  Semin Pediatr Surg       Date:  2006-02       Impact factor: 2.754

7.  Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.

Authors:  T Ara; M Fukuzawa; T Oue; Y Komoto; T Kusafuka; K Imura; A Okada
Journal:  J Pediatr Surg       Date:  1997-12       Impact factor: 2.545

Review 8.  Hepatoblastoma: assessment of criteria for histologic classification.

Authors:  Jon M Rowland
Journal:  Med Pediatr Oncol       Date:  2002-11

9.  DNA analysis in hepatoblastoma by flow and image cytometry.

Authors:  D Schmidt; P Wischmeyer; I Leuschner; E Sprenger; E Langenau; D von Schweinitz; D Harms
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

10.  Flow cytometric analysis of the nuclear DNA content of hepatoblastoma.

Authors:  Y Hata; H Ishizu; K Ohmori; H Hamada; F Sasaki; J Uchino; K Inoue; H Naitoh; M Fujita; T Kobayashi
Journal:  Cancer       Date:  1991-12-15       Impact factor: 6.860

View more
  5 in total

1.  Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.

Authors:  Goutam Bera; Ram Narayan Das; Paromita Roy; Ranajoy Ghosh; Nelofar Islam; Prafulla Kumar Mishra; Uttara Chatterjee
Journal:  Pediatr Surg Int       Date:  2017-06-19       Impact factor: 1.827

Review 2.  Primary malignant liver tumors in children.

Authors:  Sandeep Agarwala
Journal:  Indian J Pediatr       Date:  2012-03-01       Impact factor: 1.967

3.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

4.  NOX1 supports the metabolic remodeling of HepG2 cells.

Authors:  Katharina Bertram; Cristina-Maria Valcu; Michael Weitnauer; Uwe Linne; Agnes Görlach
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

Review 5.  Hepatoblastoma: current understanding, recent advances, and controversies.

Authors:  Piotr Czauderna; Hanna Garnier
Journal:  F1000Res       Date:  2018-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.